News about Utah Medical Products

Utah Medical Products (UTMD) reported third-quarter 2026 revenue of $8,621 thousand, down 12.1% from $9,812 thousand a year earlier, and nine-month revenue fell $3,602 thousand (12.1%). The drop mainly reflects no 2026 sales to former top customers PendoTECH and a China BPM kit distributor, plus a 32.7% fall in Filshie Clip System sales, partly offset by new biopharm sales and the Orion Medical Supplies acquisition. Gross profit fell $764 thousand in the quarter, but operating income improved as litigation and amortization expenses dropped to $228 thousand from $920 thousand, and net income rose about 6%. The company stayed debt-free, with cash and investments of $85.2 million at September 30, 2026, versus $85.8 million at year-end 2025, after dividends, buybacks and the $5.0 million Orion purchase.